Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY:BDX)

179.38 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
2 Medical Stocks to Watch Heading Into 2023
The two healthcare companies easily outdid the S&P 500 this year. 
Via The Motley Fool
Embecta Stock Tumbles On Mixed Q4 Results, Softer Guidance
 
Via Benzinga
2 Top Dividend Kings to Buy for the Long Haul
No matter how much changes, these two healthcare giants keep performing. 
Via The Motley Fool
Reliable Passive Income: an Analysis on Dividend Kings
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat. 
Via The Motley Fool
What 4 Analyst Ratings Have To Say About Becton, Dickinson
 
Via Benzinga
5 Analysts Have This to Say About Becton, Dickinson
  Within the last quarter, Becton, Dickinson (NYSE:BDX) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
NIO To $34? Plus This Analyst Sees $245 For Becton, Dickinson and Company
Piper Sandler cut the price target on Becton, Dickinson and Company (NYSE: BDX) from $255 to $245. Piper Sandler analyst Jason Bednar maintained the stock with a Neutral. Becton, Dickinson shares... 
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,700 Today
Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 20 years by 3.41% on an annualized basis producing an average annual return of 11.05%. Currently, Becton, Dickinson has a market... 
Via Benzinga
Becton Dickinson's FY23 Guidance Trails Wall Street View Reflecting Foreign Currency Impact
 
Via Benzinga
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report. 
Via MarketBeat
Topics Death
Got $5,000? Buy These 3 Dividend Kings And Hold Them Forever
These healthcare companies should stay relevant for years as they continue to innovate with new products. 
Via The Motley Fool
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug 
Via MarketBeat
Topics Economy
BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
From BIOCORP
Via Business Wire
Becton Dickinson To Rally 23%? This Analyst Predicts $210 For NVIDIA
Citigroup cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $248 to $210. NVIDIA shares rose 1.2% to $118.12 on Tuesday. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Becton, Dickinson
Within the last quarter, Becton, Dickinson (NYSE:BDX) has observed the following analyst ratings: 
Via Benzinga
Tesla's Stock Weakness Presents Opportunity, BMW Posts Lower Quarterly Sales, Lockheed To Resume Delivery Of F-35 Jets: Top Stories Monday, Oct. 10
Reuters 
Via Benzinga
Becton Dickinson Recalls Some Sterilization Containers Over Breached Quality
Becton, Dickinson & Co (NYSE: BDX) has issued a voluntary recall of some models of Genesis Sterrad brand's sterilization containers after finding some of the containers may have had breaches that could... 
Via Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
 
Via Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
3 Defensive Stocks With 60-Year Dividend Hike Streaks
With the U.S. economy staring at another recession, it may be a good time to lean on the stability and income of the dividend growth champs. 
Via MarketBeat
Topics Economy
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
3 Hidden Gem Stock Picks to Beat the September Market Slump
If you want to find hidden gem stock picks to buy for the September slump, you have to go where others don’t or won’t. 
Via InvestorPlace
If You Invested $100 In This Stock 15 Years Ago, You Would Have $300 Today
Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 15 years by 1.67% on an annualized basis producing an average annual return of 8.44%. Currently, Becton, Dickinson has a market... 
Via Benzinga
What Are Whales Doing With Becton, Dickinson
Someone with a lot of money to spend has taken a bearish stance on Becton, Dickinson (NYSE:BDX). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30
Reuters Taiwan’s China Airlines Orders 16 Boeing 787s 
Via Benzinga
Becton Dickinson To Pay $4.8M In Hernia Mesh Lawsuit, Second Within Six Months
Becton Dickinson and Co's (NYSE: BDX) unit, C.R. Bard Inc, was ordered to pay $4.8 million in a lawsuit related to its hernia repair mesh. The company faces more than 30,000 similar lawsuits over its... 
Via Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
Salesforce To $273? Plus This Analyst Boosts Price Target On Snowflake
Morgan Stanley cut the price target on Salesforce, Inc. (NYSE: CRM) from $291 to $273. Salesforce shares fell 1.7% to trade at $187.83 on Tuesday. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.